CD24 and cancer: Our study is the largest to date to describe distribution of CD44, CD24, an ALDH1A1 in normal tissue and benign lesions from cancer-free women (including their heterogeneity across the cores for a woman), and to investigate, for the first time, the agreement between manual assessment and that from automated image analysis with Definiens.